FDA designates T-DXd plus pertuzumab as breakthrough therapy for HER2-positive metastatic breast cancer, promising improved ...

Michael Hassett, MD, MPH, Dana-Farber Cancer Institute, reflects on the impact of HER2 identification on the breast cancer ...

As researchers keep looking for ways to deescalate treatment in HER2-positive breast cancer, a trial from China looked at a chemotherapy-free regimen with endocrine therapy, a CDK4/6 inhibitor, and ...

Omitting carboplatin could be an efficacious de-escalated neoadjuvant strategy in the presence of dual HER2 blockade for patients with HER2-positive early breast cancer,” said Kun Wang, MD, PhD.

In this video, Nancy U. Lin, MD, highlights practice-changing trials in the HER2-positive metastatic breast cancer space.

Burn Affinity is one of the many Pictos you can acquire in Clair Obscur: Expedition 33, but where can you find it and what does it ...

Olivia Munn shares how a risk assessment test led to her mom’s early HER2 breast cancer diagnosis. Read ahead to know why risk assessment matters and how it can save lives.

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug powerhouse and has become one of the world’s most successful female ...

Munn, 44, shared the news in an Instagram post, revealing that her mother, Kim Munn, was diagnosed with Stage 1 HER2 breast cancer after scoring 26.2% on a Breast Cancer Lifetime Risk Assessment test.

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with chemotherapy, according to interim data from a late-stage study.